GLP-2 is a hormone that quietly does some of the most interesting work in the gut. While its sibling GLP-1 grabs headlines for metabolic research, GLP-2 specializes in growing and repairing the intestinal lining. This article reviews the biology and research applications of GLP-2 and its analogues.
What GLP-2 Is and Where It Comes From
GLP-2 is a 33-amino-acid hormone secreted from intestinal L-cells, the same cells that release GLP-1. The two hormones come from the same precursor protein but go on to do very different jobs.
GLP-1 is best known for influencing insulin secretion, glucose handling, and appetite. GLP-2, by contrast, is the body's main intestinotrophic factor — meaning it specifically supports growth of the intestinal mucosa, the lining responsible for absorbing nutrients and forming a barrier against gut contents.
How GLP-2 Works
GLP-2 binds to GLP-2 receptors on intestinal subepithelial myofibroblasts and enteric neurons. Activation of these receptors triggers release of secondary growth factors, which then act on the epithelial cells lining the gut.
Drucker and colleagues (1996) first characterized GLP-2 as an intestinotrophic factor, showing it increased small bowel mass and villus height in mice. Since then, the picture has expanded to include effects on epithelial proliferation, reduced apoptosis, and improved barrier function.
GLP-2 analogues, such as teduglutide, were developed to extend the very short half-life of native GLP-2. The modified analogue is more stable and has been studied in clinical settings related to short bowel syndrome.
Research Applications
The most prominent research area is short bowel syndrome, a condition in which the intestine cannot absorb enough nutrients due to surgical removal or damage. Jeppesen et al. (2001) showed teduglutide increased intestinal wet weight absorption and reduced fecal output in patients with short bowel syndrome — a landmark finding that grounded subsequent clinical research.
Beyond that, GLP-2 and its analogues are studied in inflammatory bowel disease models, post-surgical recovery models, and basic research on gut barrier function. Endpoints commonly include villus height, crypt depth, epithelial proliferation markers, and barrier permeability.
Open Questions in GLP-2 Research
While the core role of GLP-2 as an intestinal growth factor is well established, several questions remain open. Researchers continue to study how chronic GLP-2 receptor activation affects long-term gut homeostasis. There is also interest in whether GLP-2 plays roles outside the gut — bone metabolism and central nervous system signaling have come up in recent literature.
Comparisons between native GLP-2, its analogues, and combination approaches with other incretins are another active area. Each carries different stability and signaling profiles.
Much about GLP-2 biology, especially its long-term effects and tissue-specific roles, is still under investigation. All compounds discussed here are intended for research use only and are not for human consumption.